glp-1 drugs adverse effects GI of Glucagon-Like Peptide-1 Receptor Agonists Adverse effects of GLP-1 receptor
Description
doi: 10.1111/j.1463-1326.2012.01567.x
Originally approved to treat diabetes, the drugs are now commonly prescribed to support weight loss and overall metabolic health
Single-receptor activation triggers these compensatory responses
Case 4: After a sleeve gastrectomy, a female patient with type 2 diabetes mellitus discontinued tirzepatide 7.5 mg as advised but resumed it independently due to rising fasting blood glucose levels
